结直肠癌和浸润性乳腺癌中 CAR-T 细胞治疗的临床新视角与挑战 Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer. PubMed 2023/08/11 发表Arch Immunol Ther Exp (Warsz)Q3 · IF 3.2(JCR 2025) 靶点:CD19靶点:CD20靶点:CD22技术:CAR-T血液系统恶性肿瘤结直肠癌乳腺癌
CD22 在三阴性乳腺癌中的表达:一种新型预后生物标志物和 CAR 治疗的潜在靶点 Expression of CD22 in Triple-Negative Breast Cancer: A Novel Prognostic Biomarker and Potential Target for CAR Therapy. PubMed 2023/01/21 发表Int J Mol SciQ1 · IF 5.6(JCR 2025) 靶点:CD22靶点:HER2技术:CAR-T乳腺癌血液系统恶性肿瘤地区:中国